Clinical Trial

Dosing of LT4 in Older Individuals

Study acronym: DOT4
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Our overall goal is to determine the clinical consequences of allowing greater flexibility in LT4 dosing in older individuals who take LT4.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-10-02; most recent amendment 2026-02-17.
Status change: Not Yet Recruiting → Recruiting 2024-02-21
Trial Details
NCT Number NCT06073665
Lead Sponsor University of Pennsylvania
Collaborators: National Institute on Aging (NIA)
Conditions Hypothyroidism
Enrollment 228 participants
Start Date 2024-01-31
Primary Completion 2028-04-01 (estimated)
Study Completion 2028-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-19